优化组合向免疫毒素治疗:从HER2和EpCAM表达特征的洞察力
A S Obozina1, A A Pakhomov2, A Yu Frolova2
1Moscow Center for Advanced Studies, Kulakova Str. 20, 123592, Moscow, Russia.
Biochemical and biophysical research communications
|January 3, 2025
概括
结合向癌症疗法和HER2和EpCAM免疫毒素,在特定的癌细胞中显示出协同效应. 最佳的疗效需要高的HER2和适度的EpCAM表达,以改善治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 针对癌症的向单疗法面临着由于多药耐药性的挑战.
- 使用多种向药物的组合疗法可以通过参与不同的信号通路来克服抵抗.
研究的目的:
- 研究抗HER2和抗EpCAM免疫毒素对癌细胞的联合疗效.
- 确定 HER2/EpCAM 向治疗中协同效应的最佳条件.
主要方法:
- 使用的抗HER2 (DARP_9.29-LoPE) 和抗EpCAM (DARP_EC1-LoPE) 免疫毒素.
- 评估了对不同HER2和EpCAM表达水平的癌细胞的影响.
- 采用Chou-Talalay组合指数来评估协同效应.
主要成果:
- 结合HER2/EpCAM疗法在具有低HER2和高EpCAM表达的细胞中效果较差.
- 在具有高HER2和中度EpCAM表达的细胞中观察到协同治疗效应.
- 免疫毒素的等分比被证明是最有效的协同结果.
结论:
- 确定了最佳组合治疗的特定表达水平 (高HER2,中等EpCAM).
- 研究结果指导开发更有效的双重向癌症治疗方法.
- 优化组合HER2/EpCAM疗法可以提高治疗效率并克服耐药性.
相关概念视频
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


